Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05288452Not ApplicableActive Not Recruiting

Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)

Role: collaborator

NCT05956457Not ApplicableRecruiting

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Role: lead

NCT05349227Not ApplicableRecruiting

Comprehensive Outcomes for After Cancer Health

Role: lead

NCT05053607Not ApplicableRecruiting

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

Role: lead

NCT05064787Not ApplicableCompleted

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Role: lead

NCT05199961Not ApplicableTerminated

Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel

Role: lead

All 6 trials loaded